Physician profile
John S Burnham
NPI 1790766012
$213.61
in general payments reported to CMS, 2019-2025
11 companies · $76.77 in 2025
The $76.77 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.88 · 2020: $14.74 · 2023: $12.95 · 2024: $84.27 · 2025: $76.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $37.51 | 2024-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $27.98 | 2023-2024 | Vraylar |
| Xeris Pharmaceuticals, INC. | $24.81 | 2025 | Gvoke Hypopen |
| Phathom Pharmaceuticals, INC. | $19.67 | 2024 | Voquezna |
| Pfizer INC. | $19.56 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.34 | 2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $14.74 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.04 | 2025 | Eliquis |
| Novartis Pharmaceuticals Corporation | $13.79 | 2019 | |
| Exact Sciences Corporation | $13.08 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Burnham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.